Use of Thalidomide for Refractory GI Bleeding in Patients with Continuous Flow Left Ventricular Assist Device (cfLVAD) - The Western Australian (WA) Experience

S. McClelland,H. Hayes,J. Barber, A. Hort,J. Baumwol

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2020）

引用 0|浏览4

暂无评分

摘要

Thalidomide may be a useful adjunctive therapy to decrease refractory GI bleeding due to angiodysplasia in cfLVAD patients, though longer term therapy is limited by side effects.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要